✦ LIBER ✦

Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus

✍ Scribed by K. R. HERRLINGER; D. N. BARTHEL; K. J. SCHMIDT; J. BÜNING; C. S. BARTHEL; J. WEHKAMP; E. F. STANGE; K. FELLERMANN

Book ID: 108605891
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 112 KB
Volume: 31
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2010.04267.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of infliximab as res

Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus

✍ Shuji Yamamoto; Hiroshi Nakase; Minoru Matsuura; Yusuke Honzawa; Satohiro Masuda 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Infliximab or cyclosporine as rescue the

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: A retrospective observational study

✍ Mats Sjöberg; Andrea Walch; Mina Meshkat; Anders Gustavsson; Gunnar Järnerot; Ha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Background: Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives. Methods: Outcome of rescue therapy was retrospectively studied in two cohorts of pati